These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18475085)

  • 21. Regulatory T cell therapy as individualized medicine for asthma and allergy.
    Xystrakis E; Urry Z; Hawrylowicz CM
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):535-41. PubMed ID: 17989531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced central tolerance in Omenn syndrome leads to immature self-reactive oligoclonal T cells.
    Somech R; Simon AJ; Lev A; Dalal I; Spirer Z; Goldstein I; Nagar M; Amariglio N; Rechavi G; Roifman CM
    J Allergy Clin Immunol; 2009 Oct; 124(4):793-800. PubMed ID: 19767069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
    Wang LH; Lin YH; Yang J; Guo W
    Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
    Meier P; Meier R; Blanc E
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy.
    Gaardbo JC; Nielsen SD; Vedel SJ; Ersbøll AK; Harritshøj L; Ryder LP; Nielsen JO; Kolte L
    Clin Exp Immunol; 2008 Oct; 154(1):80-6. PubMed ID: 18821942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent thymic origin, differentiation, and turnover of regulatory T cells.
    Mabarrack NH; Turner NL; Mayrhofer G
    J Leukoc Biol; 2008 Nov; 84(5):1287-97. PubMed ID: 18682578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion.
    Miyara M; Wing K; Sakaguchi S
    J Allergy Clin Immunol; 2009 Apr; 123(4):749-55; quiz 756-7. PubMed ID: 19348913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Foxp3 protein expression in porcine T lymphocytes.
    Käser T; Gerner W; Hammer SE; Patzl M; Saalmüller A
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):92-101. PubMed ID: 18565594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
    Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
    J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding FOXP3: progress towards achieving transplantation tolerance.
    Long E; Wood KJ
    Transplantation; 2007 Aug; 84(4):459-61. PubMed ID: 17713426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.
    Zhang Y; Wang HB; Chi LJ; Wang WZ
    Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells.
    Akdis CA; Akdis M
    J Allergy Clin Immunol; 2009 Apr; 123(4):735-46; quiz 747-8. PubMed ID: 19348912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding and converting regulatory T cells: a horizon for immunotherapy.
    Khattar M; Chen W; Stepkowski SM
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8+ suppressor T cells resurrected.
    Kapp JA; Bucy RP
    Hum Immunol; 2008 Nov; 69(11):715-20. PubMed ID: 18817830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581.
    Banham AH; Pulford K
    Expert Opin Ther Pat; 2009 Jul; 19(7):1023-8. PubMed ID: 19456276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection.
    Dijke IE; Korevaar SS; Caliskan K; Balk AH; Maat AP; Weimar W; Baan CC
    Transplantation; 2009 Apr; 87(8):1191-200. PubMed ID: 19384166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.